Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer

Antiemesis

(2017) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

(2012) M. Aapro et al.   ANNALS OF ONCOLOGY

Characteristics of taste disorders

(2012) T. Fark et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma

(2011) Mariela Blum et al.   Future Oncology

Safety of capecitabine: a review

(2010) Sameh E Mikhail et al.   Expert Opinion On Drug Safety

Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer

(2009) Giuseppe Aprile et al.   ANTI-CANCER DRUGS

S-1: a promising new oral fluoropyrimidine derivative

(2009) Muhammad Wasif Saif et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Taste and Smell Changes in Patients Receiving Cancer Chemotherapy

(2008) Britt-Marie Bernhardson et al.   CANCER NURSING

Capecitabine in the treatment of advanced gastric cancer

(2008) Jae-Lyun Lee et al.   Future Oncology

Prevention of Docetaxel- or Paclitaxel-Associated Taste Alterations in Cancer Patients with Oral Glutamine: A Randomized, Placebo-Controlled, Double-Blind Study

(2008) F. Strasser et al.   ONCOLOGIST